The Forum > General Discussion > Fraudulent Nature of the Pharmaceutical Investment Business
Fraudulent Nature of the Pharmaceutical Investment Business
- Pages:
-
- 1
- 2
- Page 3
- 4
-
- All
The National Forum | Donate | Your Account | On Line Opinion | Forum | Blogs | Polling | About |
Syndicate RSS/XML |
|
About Us :: Search :: Discuss :: Feedback :: Legals :: Privacy |
Are you suggesting a pharmaceutical company actually engineers their products to perform at a less than optimum level to ensure patients remain dependent upon them?
Often “cure” is not an option. However, “management” and “containment” is.
I think penicillin can cure the gonorrhea but not syphilis. Would you suggest because penicillin fails to cure syphilis that we ignore its contribution to curing the clap?
“What did his doc prescribe for him. . . .?”
My Dad, like the rest of his generation, lacked the benefit of bypass surgery or contemporary medications (such things having only been developed since he passed away).
Would I change from what has been prescribed for me – not in a fit, the anti-cholesterol meds keep my problems under control, the alternative would be to walk around and feel like a time bomb.
“There are charts available explaining in detail disease drop "before vaccinations & after introduction" of same. Can't give you the details where the file is,”
It was your claim
“Building this ‘business with disease’ over the past century,”
To which I asked
“Do you have estimates of average life expectancy had this industry not existed?”
The onus is on you to substantiate your claim, not for me to disprove it. Please provide evidence that pharmaceutical companies have built a business with disease, rather than a business focused on managing disease conditions, where cures for conditions are not available?
400 or 400%, I doubt the reality of your claims. I am an accountant by profession. Talking margins and markups is part of my “stock in trade” and your claims are dependent upon limited costing practices which would exclude the major “fixed costs” or research, development, testing, corporate overhead, business finance and most other charges commonly carried by a pharmaceutical company.
I lost my dad to heart disease in the 1980’s, as I said, his quality of life, as well as its duration would have been significantly enhanced and extended had he had access to the drugs which pharmaceutical companies have developed since his death.